These results were confirmed to be reproducible in the extended cohort of ROP with a significant increased expression of activated MMP2 in severe ROP (p = 0.0023) and progressive ROP (p = 0.007) as compared to mild ROP (p = 0.01) and premature controls. The gene discussed is MMP2; the disease is retinopathy of prematurity.